
    
      This is a 5-period crossover study. Each Treatment Period is 1 day. Subjects will receive a
      single dose of randomized study drug at each of the 5 Treatment Visits (Visits 2, 3, 4, 5,
      and 6), with a 3- to 7-day Washout Period between Treatment Visits.
    
  